Has Steven Schepens, MD received payments from drug or device companies?

Yes. Drug and device makers reported $11,971 in general payments to Steven Schepens, MD across 751 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Steven Schepens, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Steven Schepens, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Steven Schepens, MD

Family Medicine · Gulfport, MSNPI 1982719779

Payments from drug & device makers

$11,971in general payments, 2019–2025

Across 751 payments — averaging $15.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novo Nordisk$1K
AbbVie$1K
GSK$1K
Lilly USA, LLC$1K
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$909
AstraZeneca$770
plus $6K from 34 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novo Nordisk	67	$1,333
AbbVie(2 entities)	88	$1,250
GSK	77	$1,033
Lilly USA, LLC	70	$1,022
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	55	$909
AstraZeneca	47	$770
Pfizer	50	$749
Merck	38	$684
UCB, Inc.	25	$542
Amgen	30	$439
Boehringer Ingelheim	24	$356
Johnson & Johnson	23	$344
Astellas Pharma US Inc	18	$301
Biohaven Pharmaceuticals, Inc.	14	$240
Takeda Pharmaceuticals U.S.A., Inc.	17	$239
Amarin Pharma, Inc.	14	$220
Biohaven Pharmaceutical Holding Company Ltd.	12	$210
Kowa Pharmaceuticals America, Inc.	14	$208
Exact Sciences	8	$133
Esperion Therapeutics, Inc.	8	$110
Nestle Healthcare Nutrition Inc.	5	$87
Teva Pharmaceuticals USA, Inc.	6	$82
Abbott	5	$81
Antares Pharma, Inc.	4	$75
Shire North American Group Inc	5	$72
Supernus Pharmaceuticals, Inc.	3	$64
Almatica Pharma LLC	3	$56
Sumitomo Pharma America, Inc.	3	$53
Mylan Specialty L.p.	3	$40
Lundbeck LLC	1	$39
Idorsia Pharmaceuticals US Inc	2	$35
Phathom Pharmaceuticals, Inc.	2	$32
SK Life Science, Inc.	2	$32
Sunovion Pharmaceuticals Inc.	2	$27
Xeris Pharmaceuticals, Inc.	1	$24
Neurocrine Biosciences, Inc.	1	$19
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	1	$18
Bayer	1	$16
Gilead	1	$15
Genentech USA, Inc.	1	$13

How this compares

$11,971 in reported general payments places this provider in the 95th percentile of 971 family medicine providers in Mississippi.

See all family medicine providers in Mississippi →

Medicare billing

Part B allowed, 2024

$93,620

Medicare patients

260

Services billed

1,728

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Gulfport

Paul MatherneGulfport$14.4M
Sean KerbyGulfport$6.6M
Kathy KeimigGulfport$20K
Jonathan HamiltonGulfport$16K
Dimitrios DimitriadesGulfport$13K
Matthew BosargeGulfport$10K
Timothy QuinnRidgeland$8M
Rambod RouhbakhshHattiesburg$6M
Randall HulingOlive Branch$4.6M
Demetri MarshallPort Gibson$3M

See the full list for Mississippi →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →